Literature DB >> 20580176

Linking human beta retrovirus infection with primary biliary cirrhosis.

A L Mason1, G Zhang.   

Abstract

Several environmental agents have been linked with primary biliary cirrhosis (PBC) that include bacteria, xenobiotics and viruses. A human beta retrovirus (HBRV) related to mouse mammary tumor virus has been cloned and characterized from patients with PBC. This agent can be detected in the majority of patients' perihepatic lymph nodes by immunochemistry and RT-PCR. The HBRV has recently been isolated in culture and integration sites have been identified in the genome of patients to provide convincing evidence of beta retrovirus infection in patients. Three lines of evidence support a role for the virus in PBC. First, the beta retrovirus is linked with aberrant expression of mitochondrial protein(s) on the biliary epithelium cell (BEC) surface, a disease specific phenotype. Second, the related agent, mouse mammary tumor virus has been linked with autoimmune biliary disease in the NOD.c3c4 mouse model for PBC. In this mouse model, the virus is localized to diseased biliary epithelium that also display aberrant expression of the mitochondrial autoantigens. In translational studies, both patients with PBC and NOD.c3c4 mice demonstrate significant improvement in biliary disease with combination antiviral therapy. An overview of the biological relevance of the beta retrovirus infection in PBC will be discussed in this review. Copyright 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20580176     DOI: 10.1016/j.gcb.2010.04.014

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  11 in total

Review 1.  Primary biliary cirrhosis: From bench to bedside.

Authors:  Elias Kouroumalis; George Notas
Journal:  World J Gastrointest Pharmacol Ther       Date:  2015-08-06

Review 2.  Novel therapeutic targets in primary biliary cirrhosis.

Authors:  Jessica K Dyson; Gideon M Hirschfield; David H Adams; Ulrich Beuers; Derek A Mann; Keith D Lindor; David E J Jones
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-02-03       Impact factor: 46.802

3.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 4.  Combination antiretroviral studies for patients with primary biliary cirrhosis.

Authors:  Ellina Lytvyak; Aldo J Montano-Loza; Andrew L Mason
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

5.  Differential binding of pyruvate dehydrogenase complex-E2 epitopes by DRB1*08:01 and DRB1*11:01 Is predicted by their structural motifs and correlates with disease risk.

Authors:  I-Ting Chow; Eddie A James; Theresa J Gates; Venus Tan; Antonis K Moustakas; George K Papadopoulos; William W Kwok
Journal:  J Immunol       Date:  2013-03-29       Impact factor: 5.422

6.  The latest research trends in primary biliary cholangitis: a bibliometric analysis.

Authors:  Yu Zhao; Zhenjie Yin; Huang Du; Kangming Huang; Fajing Zhang; Hongbin Chen
Journal:  Clin Exp Med       Date:  2022-04-07       Impact factor: 3.984

7.  Identification, characterization, and comparative genomic distribution of the HERV-K (HML-2) group of human endogenous retroviruses.

Authors:  Ravi P Subramanian; Julia H Wildschutte; Crystal Russo; John M Coffin
Journal:  Retrovirology       Date:  2011-11-08       Impact factor: 4.602

8.  Immunopathogenesis of primary biliary cirrhosis: an old wives' tale.

Authors:  Daniel S Smyk; Eirini I Rigopoulou; Ana Lleo; Robin D Abeles; Athanasios Mavropoulos; Charalambos Billinis; Pietro Invernizzi; Dimitrios P Bogdanos
Journal:  Immun Ageing       Date:  2011-12-02       Impact factor: 6.400

Review 9.  Is there a role for cyclophilin inhibitors in the management of primary biliary cirrhosis?

Authors:  Shawn T Wasilenko; Aldo J Montano-Loza; Andrew L Mason
Journal:  Viruses       Date:  2013-01-24       Impact factor: 5.048

10.  A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers.

Authors:  Ori Braitbard; Maayan Roniger; Allan Bar-Sinai; Dana Rajchman; Tamar Gross; Hillel Abramovitch; Marco La Ferla; Sara Franceschi; Francesca Lessi; Antonio Giuseppe Naccarato; Chiara M Mazzanti; Generoso Bevilacqua; Jacob Hochman
Journal:  Oncotarget       Date:  2016-04-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.